{"title":"双层纳米纤维的制备、理化表征和硅学评估--作为一种潜在的克罗恩持续给药敷料","authors":"Nazanin Goshtasbi, Fatemeh Mehryab, Seyed Alireza Mortazavi, Raziyeh Ghorbani, Azadeh Haeri","doi":"10.1007/s12247-024-09838-6","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>This research aimed to produce zein-based bilayer nanofibers to sustain the release of crocin. Zein and gelatin were blended to form the drug-eluting layer, while polycaprolactone (PCL) was used to fabricate the backing layer.</p><h3>Methods</h3><p>Bilayer nanofibers were fabricated through sequential electrospinning. For fabricating the drug-eluting layer, zein solutions at the concentrations of 30% and 40% w/v were prepared and blended with gelatin solution (20% w/v) at four zein/gelatin solution mass ratios. After finding the optimized solution, PCL (12% w/v) was electrospun on the drug-eluting layer. The prepared nanofibers were characterized regarding morphology, FTIR, XRD, water contact angle, swelling, in vitro release, and mechanical properties. Molecular docking studies were also used to demonstrate interactions in crocin-zein and crocin-gelatin complexes.</p><h3>Results</h3><p>SEM micrographs showed that the ideal nanofibers consisted of zein 40% w/v and gelatin 20% w/v with a zein/gelatin solution mass ratio of 80:20. These nanofibers had an average diameter of ~ 500 nm and showed a good yield in the production process. Solid state characterizations (FTIR and XRD) demonstrated compatibility between crocin and the polymers. The bilayer nanofibers exhibited sustained release of crocin (up to 56.6% in 5 days) by preventing the shrinkage of the zein/gelatin nanofibers. Additionally, the bilayer nanofibers exhibited improved mechanical properties. Computational characterization showed favorable binding energies of -5.9 kcal/mol for the gelatin-crocin complex and -5.6 kcal/mol for the zein-crocin complex.</p><h3>Conclusion</h3><p>Based on the findings, it appears that the zein-based bilayer nanofibers could be an effective delivery system for crocin, potentially providing a sustained release for localized applications.</p><h3>Graphical Abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"19 3","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fabrication, Physicochemical Characterization, and in Silico Evaluation of Bilayer Nanofibers as a Potential Sustained Crocin Delivery Dressing\",\"authors\":\"Nazanin Goshtasbi, Fatemeh Mehryab, Seyed Alireza Mortazavi, Raziyeh Ghorbani, Azadeh Haeri\",\"doi\":\"10.1007/s12247-024-09838-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>This research aimed to produce zein-based bilayer nanofibers to sustain the release of crocin. Zein and gelatin were blended to form the drug-eluting layer, while polycaprolactone (PCL) was used to fabricate the backing layer.</p><h3>Methods</h3><p>Bilayer nanofibers were fabricated through sequential electrospinning. For fabricating the drug-eluting layer, zein solutions at the concentrations of 30% and 40% w/v were prepared and blended with gelatin solution (20% w/v) at four zein/gelatin solution mass ratios. After finding the optimized solution, PCL (12% w/v) was electrospun on the drug-eluting layer. The prepared nanofibers were characterized regarding morphology, FTIR, XRD, water contact angle, swelling, in vitro release, and mechanical properties. Molecular docking studies were also used to demonstrate interactions in crocin-zein and crocin-gelatin complexes.</p><h3>Results</h3><p>SEM micrographs showed that the ideal nanofibers consisted of zein 40% w/v and gelatin 20% w/v with a zein/gelatin solution mass ratio of 80:20. These nanofibers had an average diameter of ~ 500 nm and showed a good yield in the production process. Solid state characterizations (FTIR and XRD) demonstrated compatibility between crocin and the polymers. The bilayer nanofibers exhibited sustained release of crocin (up to 56.6% in 5 days) by preventing the shrinkage of the zein/gelatin nanofibers. Additionally, the bilayer nanofibers exhibited improved mechanical properties. Computational characterization showed favorable binding energies of -5.9 kcal/mol for the gelatin-crocin complex and -5.6 kcal/mol for the zein-crocin complex.</p><h3>Conclusion</h3><p>Based on the findings, it appears that the zein-based bilayer nanofibers could be an effective delivery system for crocin, potentially providing a sustained release for localized applications.</p><h3>Graphical Abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>\",\"PeriodicalId\":656,\"journal\":{\"name\":\"Journal of Pharmaceutical Innovation\",\"volume\":\"19 3\",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-05-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Innovation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s12247-024-09838-6\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Innovation","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12247-024-09838-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Fabrication, Physicochemical Characterization, and in Silico Evaluation of Bilayer Nanofibers as a Potential Sustained Crocin Delivery Dressing
Purpose
This research aimed to produce zein-based bilayer nanofibers to sustain the release of crocin. Zein and gelatin were blended to form the drug-eluting layer, while polycaprolactone (PCL) was used to fabricate the backing layer.
Methods
Bilayer nanofibers were fabricated through sequential electrospinning. For fabricating the drug-eluting layer, zein solutions at the concentrations of 30% and 40% w/v were prepared and blended with gelatin solution (20% w/v) at four zein/gelatin solution mass ratios. After finding the optimized solution, PCL (12% w/v) was electrospun on the drug-eluting layer. The prepared nanofibers were characterized regarding morphology, FTIR, XRD, water contact angle, swelling, in vitro release, and mechanical properties. Molecular docking studies were also used to demonstrate interactions in crocin-zein and crocin-gelatin complexes.
Results
SEM micrographs showed that the ideal nanofibers consisted of zein 40% w/v and gelatin 20% w/v with a zein/gelatin solution mass ratio of 80:20. These nanofibers had an average diameter of ~ 500 nm and showed a good yield in the production process. Solid state characterizations (FTIR and XRD) demonstrated compatibility between crocin and the polymers. The bilayer nanofibers exhibited sustained release of crocin (up to 56.6% in 5 days) by preventing the shrinkage of the zein/gelatin nanofibers. Additionally, the bilayer nanofibers exhibited improved mechanical properties. Computational characterization showed favorable binding energies of -5.9 kcal/mol for the gelatin-crocin complex and -5.6 kcal/mol for the zein-crocin complex.
Conclusion
Based on the findings, it appears that the zein-based bilayer nanofibers could be an effective delivery system for crocin, potentially providing a sustained release for localized applications.
期刊介绍:
The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI''s goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories:
Materials science,
Product design,
Process design, optimization, automation and control,
Facilities; Information management,
Regulatory policy and strategy,
Supply chain developments ,
Education and professional development,
Journal of Pharmaceutical Innovation publishes four issues a year.